Search
Octaverine
go.drugbank.com/drugs/DB21449ExperimentalOctaverine is a small molecule drug. The usage of the INN stem '-verine' in the name indicates that Octaverine is a spasmolytic with a papaverine-like action.
Icanbelimod
go.drugbank.com/drugs/DB21572ExperimentalIcanbelimod is a small molecule drug. The usage of the INN stem '-imod' in the name indicates that Icanbelimod is a immunomodulator, both stimulant/suppressive and stimulant.
Uplarafenib
go.drugbank.com/drugs/DB21661ExperimentalUplarafenib is a small molecule drug. The usage of the INN stem '-rafenib' in the name indicates that Uplarafenib is a Raf (rapidly accelerated fibrosarcoma) kinase inhibitor.
Fosrolapitant
go.drugbank.com/drugs/DB21723InvestigationalFosrolapitant is a small molecule drug. The usage of the INN stem '-pitant' in the name indicates that Fosrolapitant is a neurokinin NK1 (substance P) receptor antagonist.
Flezurafenib
go.drugbank.com/drugs/DB21725ExperimentalFlezurafenib is a small molecule drug. The usage of the INN stem '-rafenib' in the name indicates that Flezurafenib is a Raf (rapidly accelerated fibrosarcoma) kinase inhibitor.
Gamgertamig
go.drugbank.com/drugs/DB22765InvestigationalOM336 is under investigation in clinical trial NCT07083960 (OM336 in Autoimmune Cytopenias).
Clinofibrate
go.drugbank.com/drugs/DB09006ExperimentalClinofibrate is a fibrate drug sold and marketed in Japan.
VH3739937
go.drugbank.com/drugs/DB25287InvestigationalVH3739937 is under investigation in clinical trial NCT06533280 (VH3739937 Phase 1 Multiple Ascending Dose (MAD) Study in Healthy Volunteers Including Relative Bioavailability (RBA), Optional Food Effect … VH3739937 is a small molecule drug.
Tanogitran
go.drugbank.com/drugs/DB21367InvestigationalTanogitran is under investigation in clinical trial NCT02254057 (Tolerability and Pharmacokinetics/-Dynamics of Single Rising Doses BIBT 986 BS in Healthy Male Subjects). … Tanogitran is a small molecule drug.
Rosabulin
go.drugbank.com/drugs/DB20161InvestigationalRosabulin is a small molecule drug. Rosabulin is under investigation in clinical trial NCT00276913 (A Phase I Study of STA-5312 in Subjects With Advanced or Metastatic Solid Tumors).